Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis

OBJECTIVES: Major adjuvant therapies (ATs) for resected hepatocellular carcinoma (HCC) include chemotherapy, internal radiation therapy (IRT), interferon therapy (IFNT) and immunotherapy but the optimum regimen remains inconclusive. We aim to compare these therapies in terms of patient survival and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Gui-Qi, Shi, Ke-Qing, Yu, Hua-Jian, He, Sun-Yue, Braddock, Martin, Zhou, Meng-Tao, Chen, Yong-Ping, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627241/
https://www.ncbi.nlm.nih.gov/pubmed/26061709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627241/
https://www.ncbi.nlm.nih.gov/pubmed/26061709

Ejemplares similares